Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SMND 309

Known as: SMND-309, SMND309 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract Context In clinical practice, the promotion of neuron survival is necessary to recover neurological functions after the… Expand
Is this relevant?
2013
2013
SMND-309 is a novel derivative of salvianolic acid B, and has shown protective effects against rat cortical neuron damage in… Expand
Is this relevant?
2013
2013
The aim of the study is to investigate the direct angiogenic activities of SMND-309, a novel metabolite of salvianolic acid B, on… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
(2E)-2-{6-[(E)-2-carboxylvinyl]-2,3-dihydroxyphenyl}-3-(3,4-dihydroxyphenyl) propenoic acid, a novel compound designated SMND-309… Expand
Is this relevant?
2011
2011
The antioxidant activities of SMND-309 were investigated using different analysises including 1,1-diphenyl-2-picrylhydrazyl(DPPH… Expand
Is this relevant?
2011
2011
The human neuroblastoma SH-SY5Y were cultured in a hypoxia/hypoglyc-emia condition to induce cell apoptosis in vitro.The… Expand
Is this relevant?
2010
2010
(2E)-2-{6-[(E)-2-carboxyvinyl]-2,3-dihydroxyphenyl}-3-(3,4-dihydroxyphenyl) propenoic acid, a novel compound designated SMND-309… Expand
Is this relevant?
2009
2009
(2E)-2-{6-[(E)-2-carboxylvinyl]-2,3-dihydroxyphenyl}-3-(3,4-dihydroxyphenyl) propenoic acid, a novel compound designated SMND-309… Expand
Is this relevant?
2009
2009
SMND-309, a novel compound named (2E)-2-{6-[(E)-2-carboxylvinyl]-2,3-dihydroxyphenyl}-3-(3,4-dihydroxyphenyl) propenoic acid, is… Expand
Is this relevant?
2009
2009
SMND-309, a novel compound (2E)-2-[6-[(E)-2-carboxyvinyl]-2,3-dihydroxyphenyl]-3-(3,4-dihydroxyphenyl) acrylic acid, is a new… Expand
Is this relevant?